The human skeletal system, a dynamic structure subjected to continuous remodeling and regeneration, relies heavily on calcium to maintain its integrity. This article aims to delve into the pivotal role of calcium in bone metabolism, elucidating its implications for healthcare professionals.
Calcium, an essential mineral, is integral to bone health. About 99% of the body's calcium is stored in the bones and teeth, where it supports their structure and functionality. Calcium is also vital for intracellular signaling, neurotransmission, muscle function, and coagulation. Hence, maintaining calcium homeostasis is crucial.
Calcium homeostasis is principally controlled by the parathyroid hormone (PTH), vitamin D, and the hormone calcitonin. PTH and vitamin D increase serum calcium levels, while calcitonin decreases it. Any disruption in this delicate balance can lead to bone metabolic disorders such as osteoporosis and hypercalcemia.
Understanding the role of calcium in bone metabolism is critical for healthcare professionals. It aids in the diagnosis, prevention, and management of numerous skeletal disorders. Moreover, it underscores the importance of adequate dietary calcium intake and vitamin D for bone health. Healthcare professionals should educate patients, especially those at risk, about the importance of maintaining calcium homeostasis and the potential implications of its dysregulation.
In conclusion, calcium plays an indispensable role in bone metabolism, with its dysregulation leading to various skeletal disorders. Healthcare professionals should emphasize the importance of maintaining calcium homeostasis through adequate dietary intake and lifestyle modifications. The understanding of calcium's role in bone metabolism is not only crucial for disease management but also for preventive healthcare.
1.
Prostate cancer detection with PET CT and PET MRI is comparable.
2.
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy
3.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
4.
In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.
5.
Loncastuximab-Rituximab Boosts Response Rates in R/R Follicular Lymphoma
1.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
2.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
3.
Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models
4.
Emerging Chemo-Immunotherapy: New Agents and Mechanisms in Modern Oncology
5.
The Dangers of Supratherapeutic INR: The Need for Increased Awareness and Monitoring
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Thromboprophylaxis In Medical Settings
2.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
Post Progression Approaches After First-line Third-Generaion ALK Inhibitors
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation